Home › Cases › Drug-Induced Hyperkalaemia — Triple Whammy
Hyperkalaemia
Drug-Induced Hyperkalaemia — Triple Whammy
6 questions
Question 1 · Drug history
Correct answer: Triple whammy: ACEi (lisinopril) + K-sparing diuretic (spironolactone) + NSAID (ibuprofen) = reduced K+ excretion
Why
Triple whammy hyperkalaemia: ACEi reduces aldosterone → K+ retention. Spironolactone blocks aldosterone → more K+ retention. NSAID reduces renal prostaglandins → decreases GFR and further reduces K+ excretion. Combined effect: dangerous hyperkalaemia, often with acute kidney injury.
Key point
ACEi + K-sparing diuretic + NSAID = triple whammy. Additive K+ retention. Stop all three immediately.
Question 2 · ECG assessment
Correct answer: 12-lead ECG immediately — K+ 6.8 can cause fatal arrhythmia
Why
K+ ≥6.0 (or any symptomatic hyperkalaemia): 12-lead ECG immediately. ECG changes guide cardiac protection; a normal ECG does not make K+ ≥6.5 safe. Possible changes include peaked T waves, PR prolongation, QRS broadening, sine wave and VF/PEA; they need not occur in order. Do not wait for repeat blood — treat on clinical grounds.
Key point
K+ ≥6.0: urgent 12-lead ECG. K+ ≥6.5: treat urgently even if ECG is normal. Do not delay emergency treatment for a repeat sample.
Question 3 · Treatment with ECG changes
Correct answer: IV calcium gluconate 30 mL of 10% over 10 minutes for ECG toxicity, then insulin–glucose to shift K+
Why
Peaked T waves are ECG changes. Give calcium gluconate 30 mL of 10% IV over 10 minutes, then 10 units soluble insulin with 25 g glucose IV. Calcium protects the heart but does not lower K+. In arrest/peri-arrest, use calcium chloride 10 mL of 10% with the resuscitation team. Stop the offending drugs; arrange potassium removal and repeat monitoring.
Key point
Hyperkalaemic ECG changes → IV calcium, including peaked T waves. Then insulin–glucose; do not wait for QRS widening.
Question 4 · Stop offending drugs
Correct answer: SZC (or patiromer) for GI potassium removal; stop offending drugs, give IV fluids if hypovolaemic; urgent renal review if anuric or K+ refractory
Why
AKI reduces K+ excretion. SZC 10 g TDS orally (up to 72 h) if K+ ≥6.0 for gut removal; patiromer is an alternative. Calcium resonium is not routinely recommended for acute treatment. IV fluids if hypovolaemic. Furosemide requires urine output and suitable volume status. Anuria or refractory severe K+ → urgent renal review for dialysis.
Key point
AKI + hyperkalaemia: SZC/patiromer for gut removal. Anuric or refractory severe K+: urgent renal review for dialysis.
Question 5 · Monitoring
Correct answer: Repeat K+ at 1, 2, 4, 6 and 24 hours; BM every 30 minutes to 2 hours, then hourly to 6 hours; review AKI
Why
K+ can rebound after insulin: K+ at 1, 2, 4, 6 and 24 hours. BM at 0, 30, 60, 90 and 120 minutes, then hourly to 6 hours. Continue U&E/renal review beyond this according to AKI recovery. Discharge needs sustained potassium control, a stable recovery plan and arranged follow-up; one normal result is insufficient.
Key point
K+ at 1, 2, 4, 6 and 24 hours. BM at 0, 30, 60, 90 and 120 minutes, then hourly to 6 hours. Continue renal monitoring for AKI.
Question 6 · Medication restart
Correct answer: Keep oral ibuprofen stopped; reassess lisinopril/spironolactone indications and restart cautiously, one at a time after recovery, with U&E monitoring
Why
Stop oral ibuprofen (paracetamol instead). After AKI recovery and K+ <5.5, review why lisinopril and spironolactone were started. If still needed, agree one-at-a-time restart with the renal/HF team with U&E 1–2 weeks after each restart; earlier monitoring if clinically indicated. ACEi + MRA is appropriate when indicated (e.g. HFrEF), with close potassium monitoring.
Key point
Stop oral ibuprofen. Review ACEi/MRA indications after recovery; if needed, restart one at a time with U&E 1–2 weeks after each restart; earlier if clinically indicated.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.